drugset / Trial / NCT01662037
Bosentan Therapy in Children With Functional Single Ventricle
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Bosentan is a kind of dual endothelin receptor antagonist.The purpose of this study is to investigate if Bosentan therapy can modify the outcome of children with functional single ventricle.
Timeline
- Start
- 2010-01
- Primary completion
- 2011-09
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bosentan | Other / unclassified | 2 mg/kg | — |